We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-3.58%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$894M
AUM Growth
-$39.5M
Cap. Flow
+$692K
Cap. Flow %
0.08%
Top 10 Hldgs %
69.34%
Holding
66
New
–
Increased
8
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$267K
2
MMM icon
3M
MMM
+$180K
3
LIN icon
Linde
LIN
+$115K
4
VNT icon
Vontier
VNT
+$100K
5
V icon
Visa
V
+$77.3K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$125K
2
MO icon
Altria Group
MO
+$105K

Sector Composition

Rank Sector Weight
1 Financials 45.8%
2 Healthcare 19.87%
3 Materials 7.67%
4 Energy 6.55%
5 Industrials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
51
Prudential Financial
PRU
$42.2B
$545K 0.06%
6,350
– –
IEX icon
52
IDEX
IEX
$17.5B
$542K 0.06%
2,710
– –
ECL icon
53
Ecolab
ECL
$79.8B
$536K 0.06%
3,710
– –
VEEV icon
54
Veeva Systems
VEEV
$38.4B
$330K 0.04%
2,000
– –
ASHR icon
55
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$317K 0.04%
11,700
– –
VZ icon
56
Verizon
VZ
$196B
$296K 0.03%
7,800
– –
VYM icon
57
Vanguard High Dividend Yield ETF
VYM
$83.8B
$231K 0.03%
2,430
– –
FIS icon
58
Fidelity National Information Services
FIS
$22.1B
$213K 0.02%
2,820
– –
ALDX icon
59
Aldeyra Therapeutics
ALDX
$91.1M
$107K 0.01%
20,020
– –
ALPN
60
DELISTED
Alpine Immune Sciences Inc
ALPN
$90K 0.01%
12,445
– –
AKTX
61
Akari Therapeutics
AKTX
$13.5M
$82K 0.01%
164
– –
OCUL icon
62
Ocular Therapeutix
OCUL
$2.14B
$71K 0.01%
17,000
– –
CRVS icon
63
Corvus Pharmaceuticals
CRVS
$1.24B
$41K ﹤0.01%
49,959
– –
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2022 Portfolio in Review

As of Q3 2022, Hikari Power held 66 positions worth $894M, down 4.2% from $933M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Hikari Power opened no new positions and made no exits, leaving the 66-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 45% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power added most to Alphabet (Google) Class C in Q3 2022, an estimated $267K increase.
  • Hikari Power's biggest Q3 2022 reduction was Merck, cutting an estimated $125K.
  • Hikari Power's ten largest holdings make up 69% of its $894M portfolio in Q3 2022.
  • Hikari Power opened 0 new positions and closed 0 in Q3 2022.
  • Hikari Power's portfolio value fell 4.2% quarter-over-quarter to $894M.

Based on Hikari Power's 13F filing for Q3 2022, filed 1 Nov 2022.